Opioid-related (ORL1) receptors are enriched in a subpopulation of sensory neurons and prolonged activation produces no functional loss of surface N-type calcium channels

Journal of Physiology

Volumn 590, Issue 7, 2012, Pages 1655-1667

  Murali, Swetha S ^a   Napier, Ian A ^a   Rycroft, Beth K ^a   Christie, Macdonald J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL CAV2.2; CALCIUM CHANNEL N TYPE; CAPSAICIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ISOLECTIN B4; METENKEPHALIN; NOCICEPTIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; DOWN REGULATION; INTERNALIZATION; MALE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL; SPINAL CORD DORSAL HORN; SPINAL GANGLION;

ANALGESICS, OPIOID; ANIMALS; CALCIUM CHANNELS, N-TYPE; CAPSAICIN; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; GANGLIA, SPINAL; MALE; OPIOID PEPTIDES; PLANT LECTINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; SENSORY RECEPTOR CELLS; SPINAL CORD;

EID: 84859242127     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.228429     Document Type: Article

References (44)

1. Altier C, Khosravani H, Evans RM, Hameed S, Peloquin JB, Vartian BA et al (2006). ORL1 receptor-mediated internalization of N-type calcium channels. Nat Neurosci 9, 31-40.
2. Beedle AM, McRory JE, Poirot O, Doering CJ, Altier C, Barrere C et al (2004). Agonist-independent modulation of N-type calcium channels by ORL1 receptors. Nat Neurosci 7, 118-125.
3. Borgland SL, Connor M & Christie MJ (2001). Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganglion neurons in mouse. J Physiol 536, 35-47.
4. Braz JM, Nassar MA, Wood JN & Basbaum AI (2005). Parallel 'pain' pathways arise from subpopulations of primary afferent nociceptor. Neuron 47, 787-793.
5. Chen Y & Sommer C (2006). Nociceptin and its receptor in rat dorsal root ganglion neurons in neuropathic and inflammatory pain models: implications on pain processing. J Peripher Nerv Syst 11, 232-240.
6. Chen Y & Sommer C (2007). Activation of the nociceptin opioid system in rat sensory neurons produces antinociceptive effects in inflammatory pain: involvement of inflammatory mediators. J Neurosci Res 85, 1478-1488.
7. Connor M, Osborne PB & Christie MJ (2004). Mu-opioid receptor desensitization: is morphine different? Br J Pharmacol 143, 685-696.
8. Connor M, Vaughan CW, Chieng B & Christie MJ (1996a). Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Br J Pharmacol 119, 1614-1618.
9. 2+ in the SH-SY5Y human neuroblastoma cell line. Br J Pharmacol 118, 205-207.
10. Corbani M, Gonindard C & Meunier JC (2004). Ligand-regulated internalization of the opioid receptor-like 1: a confocal study. Endocrinology 145, 2876-2885.
11. Courteix C, Coudore-Civiale MA, Privat AM, Pelissier T, Eschalier A & Fialip J (2004). Evidence for an exclusive antinociceptive effect of nociceptin/orphanin FQ, an endogenous ligand for the ORL1 receptor, in two animal models of neuropathic pain. Pain 110, 236-245.
12. Dang VC, Chieng B, Azriel Y & Christie MJ (2011). Cellular morphine tolerance produced by βarrestin-2-dependent impairment of μ-opioid receptor resensitization. J Neurosci 31, 7122-7130.
13. Dang VC & Christie MJ (2012). Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons. Br J Pharmacol 165, 1704-1716.
14. Dang VC & Williams JT (2004). Chronic morphine treatment reduces recovery from opioid desensitization. J Neurosci 24, 7699-7706.
15. Evans RM, You H, Hameed S, Altier C, Mezghrani A, Bourinet E & Zamponi GW (2010). Heterodimerization of ORL1 and opioid receptors and its consequences for N-type calcium channel regulation. J Biol Chem 285, 1032-1040.
16. 4 are expressed by nociceptive primary sensory neurones. Brain Res 911, 101-104.
17. Hayashi S, Nakata E, Morita A, Mizuno K, Yamamura K, Kato A & Ohashi K (2010). Discovery of {1-[4-(2-{hexahydropyrrolo[3, 4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)pip eridin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity relationships. Bioorg Med Chem 18, 7675-7699.
18. 2+ channels to nociceptive transmission in rat spinal lamina I neurons. Eur J Neurosci 19, 103-111.
19. Hendrich J, Van Minh AT, Heblich F, Nieto-Rostro M, Watschinger K, Striessnig J et al (2008). Pharmacological disruption of calcium channel trafficking by the a2d ligand gabapentin. Proc Nat Acad Sci U S A 105, 3628-3633.
20. Kitchener PD, Wilson P & Snow PJ (1993). Selective labelling of primary sensory afferent terminals in lamina II of the dorsal horn by injection of Bandeiraea simplicifolia isolectin B4 into peripheral nerves. Neuroscience 54, 545-551.
21. Lambert DG (2008). The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Nat Rev Drug Discov 7, 694-710.
22. 2+ channels in rat sympathetic ganglion neurons. Neurosci Lett 296, 121-124.
23. Lewis RJ, Dutertre S, Vetter I & Christie M (2012). Conus venom peptide pharmacology. Pharmacol Rev in press.
24. Lewis RJ, Nielsen KJ, Craik DJ, Loughnan ML, Adams DA, Sharpe IA et al (2000). Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes. J Biol Chem 275, 35335-35344.
25. Liebel JT, Swandulla D & Zeilhofer HU (1997). Modulation of excitatory synaptic transmission by nociceptin in superficial dorsal horn neurones of the neonatal rat spinal cord. Br J Pharmacol 121, 425-432.
26. Meunier JC, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P et al (1995). Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377, 532-535.
27. Monteillet-Agius G, Fein J, Anton B & Evans CJ (1998). ORL-1 and mu opioid receptor antisera label different fibers in areas involved in pain processing. J Comp Neurol 399, 373-383.
28. Okuda-Ashitaka E, Minami T, Matsumura S, Takeshima H, Reinscheid RK, Civelli O & Ito S (2006). The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E2-induced allodynia, tactile pain associated with nerve injury. Eur J Neurosci 23, 995-1004.
29. Pettersson LM, Sundler F & Danielsen N (2002). Expression of orphanin FQ/nociceptin and its receptor in rat peripheral ganglia and spinal cord. Brain Res 945, 266-275.
30. Plenderleith MB & Snow PJ (1993). The plant lectin Bandeiraea simplicifolia I-B4 identifies a subpopulation of small diameter primary sensory neurones which innervate the skin in the rat. Neurosci Lett 159, 17-20.
31. Quillinan N, Lau EK, Virk M, von Zastrow M & Williams JT (2011). Recovery from μ-opioid receptor desensitization after chronic treatment with morphine and methadone. J Neurosci 31, 4434-4443.
32. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR et al (1995). Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270, 792-794.
33. Reiss D, Wichmann J, Tekeshima H, Kieffer BL & Ouagazzal AM (2008). Effects of nociceptin/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: comparison to morphine. Eur J Pharmacol 579, 141-148.
34. Rycroft BK, Vikman KS & Christie MJ (2007). Inflammation reduces the contribution of N-type calcium channels to primary afferent synaptic transmission onto NK1 receptor-positive lamina I neurons in the rat dorsal horn. J Physiol 580, 883-894.
35. Spampinato S, Di Toro R, Alessandri M & Murari G (2002). Agonist-induced internalization and desensitization of the human nociceptin receptor expressed in CHO cells. Cell Mol Life Sci 59, 2172-2183.
36. Spampinato S, Di Toro R & Qasem AR (2001). Nociceptin-induced internalization of the ORL1 receptor in human neuroblastoma cells. Neuroreport 12, 3159-3163.
37. Suder P, Kotlinska J, Smoluch MT, Sallberg M & Silberring J (1999). Metabolic fate of nociceptin/orphanin FQ in the rat spinal cord and biological activity of its released fragment. Peptides 20, 239-247.
38. 2+-permeable AMPA and reduced NR2B NMDA receptor-mediated neurotransmission at dorsal horn nociceptive synapses during inflammatory pain in the rat. J Physiol 586, 515-527.
39. Wang H, Rivero-Melián C, Robertson B & Grant G (1994). Transganglionic transport and binding of the isolectin B4 from Griffonia simplicifolia I in rat primary sensory neurons. Neuroscience 62, 539-551.
40. Wang HF, Robertson B & Grant G (1998). Anterograde transport of horseradish-peroxidase conjugated isolectin B4 from Griffonia simplicifolia I in spinal primary sensory neurons of the rat. Brain Res 811, 34-39.
41. 2+ channel currents to a mu opioid in isolectin B4-positive and -negative dorsal root ganglion neurons. J Pharmacol Exp Ther 311, 939-947.
42. 2+ channel currents in isolectin B4-positive and -negative small dorsal root ganglion neurons of rats. Neurosci Lett 368, 96-101.
43. Yamamoto T, Nozaki-Taguchi N & Kimura S (1997). Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like1 receptor agonist, in the rat formalin test. Neuroscience 81, 249-254.
44. Zeilhofer HU & Calò G (2003). Nociceptin/orphanin FQ and its receptor-potential targets for pain therapy? J Pharmacol Exp Ther 306, 423-429.